Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity: Randomized, Open-label, Parallel Group, Controlled Superiority Trial _ CHRONOSTEATOSIS

NCT07378072 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07378072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07378072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity: Randomized, Open-label, Parallel Group, Controlled Superiority Trial _ CHRONOSTEATOSIS
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 17, 2026
Completion date
June 30, 2029
Enrollment
72 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

masld (metabolic dysfunction-associated steatotic liver disease)